JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB181991

Anti-Zonula occludens protein 3/ZO3 antibody [EPR13414] - Plasma Membrane Marker

0

(1 Review)

|

(4 Publications)

Rabbit Recombinant Monoclonal Zonula occludens protein 3/ZO3 antibody. Plasma Membrane marker. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 4 publications.

View Alternative Names

ZO3, TJP3, Tight junction protein ZO-3, Tight junction protein 3, Zona occludens protein 3, Zonula occludens protein 3

2 Images
Immunocytochemistry/ Immunofluorescence - Anti-Zonula occludens protein 3/ZO3 antibody [EPR13414] - Plasma Membrane Marker (AB181991)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Zonula occludens protein 3/ZO3 antibody [EPR13414] - Plasma Membrane Marker (AB181991)

Immunofluorescent analysis of 4% paraformaldehyde-fixed MCF7 cell line staining Zonula occludens protein 3 using ab181991 at a 1/250 dilution (green). Goat anti rabbit IgG (Dylight 488) was used as a secondary antibody at a dilution of 1/200. Counter stain : Dapi (blue).

Western blot - Anti-Zonula occludens protein 3/ZO3 antibody [EPR13414] - Plasma Membrane Marker (AB181991)
  • WB

Supplier Data

Western blot - Anti-Zonula occludens protein 3/ZO3 antibody [EPR13414] - Plasma Membrane Marker (AB181991)

All lanes:

Western blot - Anti-Zonula occludens protein 3/ZO3 antibody [EPR13414] - Plasma Membrane Marker (ab181991) at 1/100000 dilution

Lane 1:

Caco2 cell lysate at 20 µg

Lane 2:

MCF7 cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 103 kDa

false

  • Carrier free

    Anti-Zonula occludens protein 3/ZO3 antibody [EPR13414] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR13414

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/100000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/250", "ICCIF-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Zonula occludens protein 3 (ZO-3) also known as Tight junction protein 3 is a component of tight junction complexes located in epithelial and endothelial cells. ZO-3 exhibits a molecular mass of approximately 130 kDa. Within the cellular environment ZO-3 serves as a scaffold protein anchoring transmembrane proteins to the actin cytoskeleton maintaining tight junction integrity. Expressions of ZO-3 occur in tissues where tight junctions are present including the intestinal epithelium and blood-brain barrier.
Biological function summary

ZO-3 participates with other proteins in maintaining cellular polarity and regulating paracellular permeability. It forms a part of the tight junction complex where it interacts with proteins like ZO-1 and occludin. Through these interactions ZO-3 contributes to the junctional barrier between adjacent cells playing an essential role in controlling the passage of molecules and ions through these cellular layers. ZO-3 also helps in signal transduction pathways linked to cellular proliferation and differentiation.

Pathways

ZO-3 plays a significant role in tight junction signaling and the establishment of epithelial cell adhesion. Within these pathways ZO-3 collaborates with ZO-1 and other junctional proteins forming a network that regulates cellular responses to extracellular stimuli. These associations reinforce the epithelial barrier and help manage processes such as inflammation and tissue repair important for maintaining tissue homeostasis.

Zonula occludens protein 3 has a connection to conditions like inflammatory bowel disease (IBD) and certain cancers. Variations or disruptions in ZO-3 expression can weaken the intestinal barrier having potentially contributing effects on the development of IBD. Furthermore ZO-3 has an association with tumor suppressor proteins like ZO-1 suggesting that its dysfunction might play a role in the progression of cancerous growths by altering barrier properties and influencing cell proliferation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

TJP1, TJP2, and TJP3 are closely related scaffolding proteins that link tight junction (TJ) transmembrane proteins such as claudins, junctional adhesion molecules, and occludin to the actin cytoskeleton (PubMed : 16129888). The tight junction acts to limit movement of substances through the paracellular space and as a boundary between the compositionally distinct apical and basolateral plasma membrane domains of epithelial and endothelial cells. Binds and recruits PATJ to tight junctions where it connects and stabilizes apical and lateral components of tight junctions (PubMed : 16129888). Promotes cell-cycle progression through the sequestration of cyclin D1 (CCND1) at tight junctions during mitosis which prevents CCND1 degradation during M-phase and enables S-phase transition (PubMed : 21411630). With TJP1 and TJP2, participates in the junctional retention and stability of the transcription factor DBPA, but is not involved in its shuttling to the nucleus (By similarity). Contrary to TJP2, TJP3 is dispensable for individual viability, embryonic development, epithelial differentiation, and the establishment of TJs, at least in the laboratory environment (By similarity).
See full target information TJP3

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

Journal of virology 99:e0146224 PubMed39745448

2025

Post-translational modifications on protein VII are important during the early stages of adenovirus infection.

Applications

Unspecified application

Species

Unspecified reactive species

Edward A Arnold,Julian R Smith,Katie Leung,Daniel H Nguyen,Laurel E Kelnhofer-Millevolte,Monica S Guo,Jason G Smith,Daphne C Avgousti

Cell death & disease 15:748 PubMed39402063

2024

GRHL2 regulates keratinocyte EMT-MET dynamics and scar formation during cutaneous wound healing.

Applications

Unspecified application

Species

Unspecified reactive species

Tianying Chen,Bo Zhang,Hanqi Xie,Chenyu Huang,Qiong Wu

Aging 15:12890-12906 PubMed37950731

2023

TJP3 promotes T cell immunity escape and chemoresistance in breast cancer: a comprehensive analysis of anoikis-based prognosis prediction and drug sensitivity stratification.

Applications

Unspecified application

Species

Unspecified reactive species

Liu Chaojun,Li Pengping,Li Yanjun,Zhu Fangyuan,He Yaning,Shao Yingbo,Chen Qi,Liu Hui

Neural regeneration research 17:812-818 PubMed34472480

2021

CircLphn3 protects the blood-brain barrier in traumatic brain injury.

Applications

Unspecified application

Species

Unspecified reactive species

Yu-Qi Cheng,Chen-Rui Wu,Meng-Ran Du,Qiang Zhou,Bi-Ying Wu,Jia-Yuan-Yuan Fu,Ehab Balawi,Wei-Lin Tan,Zheng-Bu Liao
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com